期刊
PEDIATRIC NEPHROLOGY
卷 27, 期 11, 页码 2073-2079出版社
SPRINGER
DOI: 10.1007/s00467-012-2228-3
关键词
Idiopathic nephrotic syndrome; Therapy; Cyclosporine A; Tacrolimus
资金
- National Natural Science Foundation of China [30971365, 81070561, 81170664]
- Zhejiang Provincial Healthy Science Foundation of China [WKJ2010-2-014, 2012KYA119]
- Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents
- Zhejiang Provincial Natural Science Foundation of China [Y12H050037]
Cyclosporine A (CsA) and tacrolimus (TAC) are often alternative treatment choices for patients with nephrotic syndrome. In this prospective study, the efficacy and safety of CsA and TAC in inducing and maintaining remission in 74 children with idiopathic nephrotic syndrome (INS) were evaluated. In terms of short-term efficacy, TAC was more effective than CsA in children with steroid-resistant nephrotic syndrome (chi(2) = 13.75, P = 0.001), although no significant difference in number of episodes of relapse were found in patients with complete remission between the two treatment groups (first year: chi(2) = 0.261, P = 0.88; second year: chi(2) = 2.685, P = 0.26). In patients with frequently relapsing or steroid-dependent nephrotic syndrome, no significant difference in short-term remission (chi(2) = 1.908, P = 0.39) or in relapse frequency during follow-up (within first year: chi(2) = 1.046, P = 0.59; within second year: chi(2) = 0.587, P = 0.75) were found between the two groups. There was a difference in the rate of adverse effects between the two treatment groups [nephrotoxicity: 4/24 (CsA) vs .0/50 (TAC), P = 0.002; hirsutism: 8/24 (CsA) vs. 0/50 (TAC), P < 0.001]. In our pediatric patient cohort, the treatment of steroid-resistant nephrotic syndrome with tacrolimus was associated with higher efficacy and lower renal toxicity in comparison to CsA, although no favorable outcome in relapse rate during long-term follow-up was seen. On the other hand, tacrolimus was not always the better choice to replace CsA in the treatment of severe frequently relapsing or steroid-dependent nephrotic syndrome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据